focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEfg-hold.gdr S Regulatory News (EFGD)

Share Price Information for Efg-hold.gdr S (EFGD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.70
Bid: 0.00
Ask: 0.695
Change: 0.00 (0.00%)
Spread: 0.695 (0.00%)
Open: 0.70
High: 0.00
Low: 0.00
Prev. Close: 0.70
EFGD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IFA Report on AiBank acquisition

14 Apr 2021 09:33

RNS Number : 4335V
EFG-Hermes Holdings SAE
14 April 2021
 

Click on, or paste the following link into your web browser, to view the full announcement.

http://www.rns-pdf.londonstockexchange.com/rns/4335V_1-2021-4-14.pdf

 

 

Indicative form of fair market value assessment

 

1. Brief about the Bank

Establishment & Shareholders: aiBank was established in 1974 as an investment and commercial bank. aiBank was previously known as The Federal Arab Bank for Development and Investment. As at the valuation date, the bank's shareholders were National Investment Bank("NIB") (92.2%) and Federation of Arab Republics (7.8%)

Capital & Minimum Requirement: aiBank paid up capital amounted to EGP 1.84B as at 30 Jun 2020. A subordinated loan from National Investment Bank was approved to be transferred to capital resulting in an increase in paid up capital to EGP 1.98B.

Headcount: was 956 employees as at the valuation date.

Branches & Offering: The bank currently operates through 31 branches (owned and leased), with two branches offering Islamic products; one based in Cairo and the other in Alexandria. The headquarters is currently located in downtown Cairo. However, it is planned to move to the new administrative capital after its construction completion which is currently in progress.

Historical financial information of the bank showing:

 

aiBank has incurred net losses in FY18 and FY19 due to (1) a low and fluctuating net interest margin, coupled with (2) an increase in impairment of credit loss, (3) a one-off legal provision formed in 2019 as well as (4) a reduction in net fees and commission income.

The decline in interest income & interest expense starting 2019 is in line with the reduction in Central Bank of Egypt Corridor, latest being 300 bps in Mar 2020.

OPEX comprised mainly of salaries and wages. In early 2019, a salary adjustment take place by changing the base exchange rates of salaries and wages in order to be closer to market norms.

 

 

Historical balance sheet highlights

Given the bank's CAR limitation to extend loans, management maintained an average loan to deposit ratio of c. 30% during the historical period, while 70% of the bank's funds were directed to different investments including T-Bills and Bonds, as well as deposits with other banks. The increase in loans in YTD-20 was driven by the increase in capital through equity injection from NIB coupled with a shareholder's loan that was transferred to capital.

Customer deposits have been the main source of funds for the bank over the historical period. As per discussions with management, aiBank has provided competitive rates historically which allowed the bank to increase its deposits base to EGP 38B by 31 Dec 20.

 

2. Independent Financial Advisor Report:

We were hired by the EFG Hermes Holding S.A.E. and Arab Investment Bank (the "Clients") to conduct this study in connection with the potential subscription for shares issued by aiBank (the "Purpose"). 

The principles and assumptions presented in this study are based on data and information provided to us by the Bank's Management.

It is worth noting that the future performance of the bank may vary from the estimates provided by the Bank's management as events and circumstances frequently do not occur as expected. We take no responsibility for the achievement of predicted results.

The report includes identifying the sources of information and the methodology used in the valuation.

This report has been prepared for the Board of Directors for guidance purposes only. Any investment decision remains solely a matter for the Board to assess based on the information, including the IFA Report, made available to them. 

3. Valuation Methodologies:

We have used the Discounted Cash Flows (DCF methodology) based on the business plan provided by the target's management at an appropriate discount rate and applying appropriate adjustments.

For the market approach we have relied on all listed banks in the Egyptian stock exchange and have only excluded non-actively traded banks, we have also considered most recent market transactions.

Based on the above, the DCF approach resulted in a fair value range from EGP 1.1 billion million to EGP 1.2 billion, while the market approach resulted in a valuation range from EGP 0.8 billion to EGP 1.4 billion.

4. Fair Value of the share

The fair market value of the equity is estimated to be in the range of EGP 0.9 billion and EGP 1.2 billion with the estimated value being EGP 1.1 billion.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQDKQBDFBKKFQD
Date   Source Headline
8th May 20127:00 amRNSRe Agreement
26th Apr 20129:23 amRNSStatement re. Press Comment
25th Apr 20123:45 pmRNSSecond Price Monitoring Extn
25th Apr 20123:40 pmRNSPrice Monitoring Extension
10th Apr 20127:00 amRNSFY2011 Results
28th Mar 20129:36 amRNSStatement re Damas International Limited
26th Mar 20128:49 amRNSStatement re Strategic Alliance with QInvest
19th Mar 201211:07 amRNSStatement re. Press Comment
14th Feb 20129:33 amRNSStatement re CEO Travel Ban
8th Feb 20128:33 amRNSStatement re CEO Travel Ban
6th Feb 20127:42 amRNSStatement re - CEO Travel Ban
17th Jan 20123:45 pmRNSSecond Price Monitoring Extn
17th Jan 20123:40 pmRNSPrice Monitoring Extension
16th Nov 20119:28 amRNS3rd Quarter Results
10th Oct 20113:45 pmRNSSecond Price Monitoring Extn
10th Oct 20113:40 pmRNSPrice Monitoring Extension
4th Oct 20119:53 amRNSStatement re. Press Comment
19th Sep 20113:45 pmRNSSecond Price Monitoring Extn
19th Sep 20113:40 pmRNSPrice Monitoring Extension
19th Sep 20112:00 pmRNSStatement re Bonus Shares Distribution
2nd Sep 20113:40 pmRNSPrice Monitoring Extension
15th Aug 20117:00 amRNS2nd Quarter results
11th Aug 20113:45 pmRNSSecond Price Monitoring Extn
11th Aug 20113:40 pmRNSPrice Monitoring Extension
1st Aug 20113:45 pmRNSSecond Price Monitoring Extn
1st Aug 20113:40 pmRNSPrice Monitoring Extension
19th Jul 20113:45 pmRNSSecond Price Monitoring Extn
19th Jul 20113:40 pmRNSPrice Monitoring Extension
13th Jul 20113:45 pmRNSSecond Price Monitoring Extn
13th Jul 20113:40 pmRNSPrice Monitoring Extension
6th Jul 201111:53 amRNSRegulatory Approval
27th Jun 20113:45 pmRNSSecond Price Monitoring Extn
27th Jun 20113:40 pmRNSPrice Monitoring Extension
15th Jun 20119:28 amRNS1st Quarter Results
13th Jun 201110:36 amRNSEGM & AGM Statement
6th Jun 20117:00 amRNSTreasury Stock
25th May 20119:29 amRNSNotice of AGM & EGM
10th May 20113:40 pmRNSPrice Monitoring Extension
5th May 20113:45 pmRNSSecond Price Monitoring Extn
5th May 20113:40 pmRNSPrice Monitoring Extension
4th May 20113:40 pmRNSPrice Monitoring Extension
28th Apr 20113:40 pmRNSPrice Monitoring Extension
27th Apr 20111:12 pmRNSStatement re Board of Directors
26th Apr 20113:40 pmRNSPrice Monitoring Extension
26th Apr 201110:32 amRNSStatement re Board of Directors
18th Apr 20119:51 amRNSDirectorate Change
30th Mar 20112:19 pmRNSStatement re news published on the company
30th Mar 20119:47 amRNSAnnual Financial Report
29th Mar 20115:00 pmRNSDirectorate Change
14th Feb 20117:10 amRNSStatement re clarification of ownership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.